04:36 PM EDT, 09/30/2025 (MT Newswires) -- Edward M. Kaye, Director, on September 30, 2025, sold 6,695 shares in Cytokinetics ( CYTK ) for $368,761. Following the Form 4 filing with the SEC, Kaye has control over a total of 16,535 common shares of the company, with 16,535 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000106198325000006/xslF345X05/form4.xml